Evogene to Present at Cantor Virtual Global Healthcare Conference, September 2021

Rhea-AI Summary

Evogene Ltd. (NASDAQ: EVGN) announced that President and CEO Ofer Haviv will participate in a "Fireside Chat" at the Cantor Virtual Global Healthcare Conference from September 27-30, 2021. The interview will take place on September 28, 2021, at 10:40 am EST. Haviv will discuss Evogene's innovative technologies and product development strategies across its subsidiaries. Interested investors can access the webcast at this link and can arrange meetings with Mr. Haviv through the investor relations team.

REHOVOT, Israel, Sept. 14, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational predictive biology company aiming to revolutionize life-science product development acros\s several market segments, announced today that Mr. Ofer Haviv, Evogene's President and CEO, will be interviewed in a "Fireside Chat" at the Cantor Virtual Global Healthcare Conference taking place on September 27-30, 2021. Mr. Haviv's  interview will focus on Evogene's disruptive technologies; its tailor-made engines for product discovery and development and its fields of activity through its main subsidiaries and will take place on Tuesday September 28, 2021, at 10:40 am, EST and will be available through the following webcast link: https://wsw.com/webcast/cantor12/evgn/2086560.

Investors attending the conference who wish to meet with Mr. Haviv, may contact Evogene's Investor Relations team at ir@evogene.com or through the conference's online meeting platform.

About Evogene Ltd.:

Evogene (NASDAQ: EVGN) (TASE: EVGN) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of our broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Casterra Ltd. For more information, please visit www.evogene.com.

Evogene Investor Contact:
Aviva Banczewski / Rivka Neufeld
Investor Relations and Public Relations Manager
E: IR@evogene.com 
T: +972-8-931-1900

US Investor Relations:
Joseph Green
Edison Group
E: jgreen@edisongroup.com  
T: +1 646-653-7030

Laine Yonker
Edison Group
E: lyonker@edisongroup.com  
T: +1 646-653-7035

View original content:https://www.prnewswire.com/news-releases/evogene-to-present-at-cantor-virtual-global-healthcare-conference-september-2021-301376087.html

SOURCE Evogene

FAQ

When will Evogene's CEO be interviewed at the Cantor Virtual Global Healthcare Conference?

Ofer Haviv, Evogene's CEO, will be interviewed on September 28, 2021, at 10:40 am EST.

How can I access the webcast of Evogene's interview at the conference?

You can access the webcast at this link: https://wsw.com/webcast/cantor12/evgn/2086560.

What topics will be discussed during the Fireside Chat with Evogene's CEO?

The discussion will focus on Evogene's disruptive technologies and product development strategies.

Is there an opportunity for investors to meet with Evogene's management during the conference?

Yes, investors can contact Evogene's Investor Relations team to arrange meetings.

What is the date range for the Cantor Virtual Global Healthcare Conference?

The conference will take place from September 27-30, 2021.